Otsuka Pharmaceuticals has deepened its relationship with Science 37, a startup it invested in earlier this year. Otsuka will use Science 37’s mobile clinical trial technology to further digitize its own trials, with an initial focus on psychiatry and behavioral health.
“Otsuka is dedicated to promoting innovation in clinical trials as a means of expanding the diversity of patients enrolled in...
